Abstract-Lipoprotein retention in the vascular extracellular matrix (ECM) plays a critical role in atherogenesis. Previous studies demonstrated the presence of apo A-I and E in atherosclerotic lesions, suggesting that HDL may be trapped by the artery wall. We sought to determine mechanisms by which HDL could be bound and retained by the arterial wall, and whether apo E was a principal determinant of this binding. We evaluated in situ accumulation of fluorescently labeled DiI-human HDLϮapo E in perfused carotid arteries from apo E-null mice. Apo E was important in mediating HDL binding to the vascular wall, with a 48Ϯ16% increase in accumulation of DiI-labeled apo E-containing HDL (HDL 3 ϩE) compared with DiI-apo E-free HDL (HDL 3 ϪE) (Pϭ0.003). To investigate possible mechanisms responsible for retention, we assessed binding of unlabeled HDL 3 ϪE and HDL 3 ϩE to ECM generated by cultured arterial smooth muscle cells. Similar to the in situ carotid artery data, HDL 3 ϩE bound better to the ECM than did HDL 3 ϪE (3-fold lower K a and 3.5-fold higher B max for HDL 3 ϩE versus HDL 3 ϪE). These differences were eliminated after either neutralization of arginine residues on apo E or digestion of matrix with chondroitin ABC lyase, suggesting that chondroitin and/or dermatan sulfate proteoglycans were responsible for apo E-mediated increased binding. These findings demonstrate that HDL can bind to both intact murine carotid arteries and smooth muscle cell-derived ECM, and that apo E is a principal determinant in mediating the ability of HDL to be trapped and retained via its interaction with ECM proteoglycans. Key Words: apolipoprotein E Ⅲ high-density lipoproteins Ⅲ extracellular matrix Ⅲ artery wall Ⅲ proteoglycan T he retention of lipoproteins in the arterial extracellular matrix (ECM) is a critical step in atherogenesis. 1-3 Apolipoproteins (apo) B and E, found on triglyceride-rich, atherogenic lipoproteins, have been found extensively in atherosclerotic lesions, often associated with ECM proteoglycans. 4 However, immunohistochemical studies show that apo A-I, which is the primary apolipoprotein on HDL, is present in human atherosclerotic lesions as well. 4 -7 Further, apo A-I and E were found to colocalize with biglycan, 4 a major arterial extracellular proteoglycan, suggesting that HDL can be trapped by ECM proteoglycans. We also have shown that apo E-containing HDL (HDLϩE) binds to purified matrix proteoglycans in vitro, whereas apo E-free HDL (HDLϪE) does not bind. 4,8 Because HDLϪE contains a large amount of apo A-I, this suggests that apo A-I itself does not bind to proteoglycans. This hypothesis is supported by reports that mammalian apo A-I does not contain heparin binding domains. 9 Therefore, these data indicate that apo E may play an important role in the retention of HDL by ECM proteoglycans.Because the artery wall contains ECM components in addition to proteoglycans, we conducted studies to evaluate the hypothesis that the presence of apo E on HDL could affect its retention by the intact vascular ECM. ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.